Evidence-Based Recommendations Against Neoadjuvant Chemotherapy for Routine Management of Patients with Squamous Cell Head and Neck Cancer

References

• Vokes EE, Weichselbaum RR, Lippman SM. Medical progress: Head and neck cancer. N Engl J Med 1993; 328: 184–194
   PubMed Web of Science ®Google Scholar
• Forastiere AA. Randomized trials of induction chemotherapy. Hematol/Oncol Clin North Am 1991; 5: 725–736
   PubMed Web of Science ®Google Scholar
• Kramer S, Gelber RD, Snow JB. Combined radiation and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987; 10: 19–30
   PubMedGoogle Scholar
• Jacobs C. Adjuvant and neoadjuvant treatment of head and neck cancers. Semin Oncol 1991; 18: 504–514
   PubMed Web of Science ®Google Scholar
• Clark JR, Dreyfuss AI. The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck. Semin Oncol 1991; 18: 34–48
   PubMed Web of Science ®Google Scholar
• Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85: 95–111
   PubMedGoogle Scholar
• Tannock IF, Browman GP. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 1986; 4: 1121–1126
   PubMed Web of Science ®Google Scholar
• Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J 1988; 138: 697–703
   PubMed Web of Science ®Google Scholar
• Toohill RJ, Anderson T, Byhardt RW. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report. Arch Otolaryngol Head Neck Surg 1987; 113: 758–761
   PubMed Web of Science ®Google Scholar
• Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992; 10: 890–895
   PubMed Web of Science ®Google Scholar
• Buyse M. Meta-analyses, use and misuse. J Clin Oncol 1993; 11: 382
   PubMedGoogle Scholar
• Yusuf S, Peto Lewis R.J. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335–371
   PubMed Web of Science ®Google Scholar
• Jaulerry C, Rodriguez J, Brunin F. Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials. Int J Radiat Oncol Biol Phys 1992; 23: 483–489
   PubMed Web of Science ®Google Scholar
• Holoye PY, Grossman TW, Toohill RJ. Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol Head Neck Surg 1985; 93: 712–717
   PubMed Web of Science ®Google Scholar
• Kun LE, Toohill RJ, Holoye PY. A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 1986; 12: 173–178
   PubMed Web of Science ®Google Scholar
• Knowlton AH, Percarpio B, Bobrow S. Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology 1975; 116: 709–712
   PubMed Web of Science ®Google Scholar
• Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx Concluding report of an RTOG randomized trial on 638 patients. Int J Radiat Oncol Biol Phys 1980; 6: 533–541
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Block J, Kuisk H. A randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in stage IV carcinoma of the head and neck. Cancer 1981; 47: 2259–2264
   PubMed Web of Science ®Google Scholar
• Strong EW, Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final Report of the Head and Neck Contracts Program. Cancer 1987; 60: 301–311
   PubMed Web of Science ®Google Scholar
• Schuller DE, Metch B, Stein DW. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 1988; 98: 1205–1211
   PubMed Web of Science ®Google Scholar
• Mazeron J-Martin J.M., Brun B. Induction chemotherapy in head and neck cancer: Results of a phase III trial. Head Neck 1992; 14: 85–91
   PubMed Web of Science ®Google Scholar
• Salvajoli JV, Morioka H, Trippe N. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 1992; 249: 211–215
   PubMed Web of Science ®Google Scholar
• Martin M, Hazan M.A., Vergnes L. Randomized study of 5 fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 1990; 19: 973–975
   PubMed Web of Science ®Google Scholar
• Bezwoda WR, De Moor NG, Derman DP. Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy—A randomised trial. Med Pediatr Oncol 1979; 6: 353–358
   PubMedGoogle Scholar
• Adelstein DJ, Sharan VM, Earle S. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 1990; 65: 1685–1691
   PubMed Web of Science ®Google Scholar
• Merlano M, Corvo R, Margarino G. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: The final report of a randomized trial. Cancer 1991; 67: 915–921
   PubMed Web of Science ®Google Scholar
• Merlano M, Vitale V, Rosso R. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115–1121
   PubMed Web of Science ®Google Scholar
• Taylor SG, IV, Applebaum E, Showel JL. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 1985; 3: 672–679
   PubMed Web of Science ®Google Scholar
• Rentschler RE, Wilbur DW, Petti GH. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas—A prospective, randomized study. J Clin Oncol 1987; 5: 278–285
   PubMed Web of Science ®Google Scholar
• Stolwijk C, Wagener D JT, Van Den Broek P. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med 1985; 28: 347–351
   PubMed Web of Science ®Google Scholar
• Siodlak MZ, Dalby JE, Bradley PJ. Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: Long-term results. Clin Otolaryngol 1989; 14: 17–22
   PubMed Web of Science ®Google Scholar
• Stell PM, Dalby JE, Strickland P. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 1983; 34: 463–467
   PubMed Web of Science ®Google Scholar
• Drelichman A, Cummings G, Al-Sarraf M. A randomized trial of cis-platinum. oncovin and bleomycin (COB) versus metholrexate in patients with advanced squamous cell carcinoma. Cancer 1983; 52: 399–403
   PubMed Web of Science ®Google Scholar
• Szpirglas H, Nizri D, Marneur M. Neoadjuvant chemotherapy. A randomized trial before radiotherapy in oral and oropharyngeal carcinomas: end results. Head and Neck Oncology Research, GT Wolf, TE Carey. Kugler & Ghedini, Amsterdam, Berkeley, CA 1988; 261–264
   Google Scholar
• Gotay CC, Moore TD. Assessing quality of life in head and neck cancer. Qual Life Res 1992; 1: 5–17
   PubMedGoogle Scholar
• McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: Tradeoffs between quality and quantity of life in largyngeal cancer. N Engl J Med 1981; 305: 982–987
   PubMed Web of Science ®Google Scholar
• Jacobs C, Goffinet DR, Goffinet L. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer: A report from the Northern California Oncology Group. Cancer 1987; 60: 1178–1183
   PubMed Web of Science ®Google Scholar
• Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685–1690
   PubMed Web of Science ®Google Scholar
• Mohide EA, Archibald SD, Tew M. Postlaryngectomy quality-of-life dimensions identified by patients and health care professionals. Am J Surg 1992; 164: 619–622
   PubMed Web of Science ®Google Scholar
• Cook DJ, Guyatt GH, Laupacis A. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992; 102: 305S–311S, (Suppl)
   PubMed Web of Science ®Google Scholar
• Stell PM, Rawson N SB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779–787
   PubMed Web of Science ®Google Scholar
• El-Sayed S, Nelson N. The value of adjunctive chemotherapy in squamous cell carcinoma of the head and neck region, a metaanalysis. Proceedings of the Third International Conference on Head and Neck Cancer, San Francisco, July 26–30, 1992, (abstract)
   Google Scholar
• Browman GP, Wong G, Hodson I. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328: 159–163
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1–15; 71–85
   PubMed Web of Science ®Google Scholar